Anti-ADAM-12 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibodies targeting ADAM-12, a disintegrin metalloproteinase involved in skeletal muscle regeneration, cell fusion, and osteoclast formation.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Pan, Monkey, Dog
UniProt
O43184
Size
100ug
Cat. #
RP3ADAM12

In stock

SKU
RP-ADAM12

Options

As low as: $130.00

Target Overview

Disintegrin and metalloproteinase domain-containing protein 12 (ADAM-12, also known as meltrin-alpha; UniProt O43184) is a 909-residue, cell membrane-associated metalloproteinase in the EC 3.4.24.- family. ADAM-12 is involved in skeletal muscle regeneration, specifically at the onset of myoblast fusion, and contributes to macrophage-derived giant cell and osteoclast formation from mononuclear precursors. The protein contains both disintegrin and metalloproteinase domains, enabling it to modulate cell-cell and cell-matrix interactions through proteolytic cleavage of extracellular substrates. Researchers study ADAM-12 in contexts ranging from muscle repair and fibrosis to cancer progression, where its dysregulation has been implicated in metastasis, hypoxia response, and metabolic reprogramming. Triple Point Biologics offers three rabbit polyclonal antibodies raised against the aminoterminal region of ADAM-12, validated for Western blot applications in human samples with predicted cross-reactivity in mouse, primate, and canine tissues.

Background

ADAM-12 belongs to the ADAM (a disintegrin and metalloproteinase) family of transmembrane and secreted proteins that combine proteolytic and cell adhesion functions. Its role in skeletal muscle is well established: ADAM-12 expression increases during myogenesis and is required for efficient myoblast fusion. Beyond muscle, ADAM-12 has been implicated in pathological processes including fibrosis, rheumatoid arthritis, and cancer. Recent work by Lin et al. (2026) demonstrated that ADAM-12 mediates TGF-β1-induced proliferation of rheumatoid arthritis synovial fibroblasts, suggesting a role in chronic inflammatory joint disease. In hepatocellular carcinoma, Wu et al. (2026) reported that ADAM-12 stabilizes the translation initiation factor EIF3B, promoting glycolysis and tumor progression, while Tavares et al. (2026) found differential ADAM-12 expression in hypoxic regions of salivary gland carcinomas alongside HIF-1α, NOTCH-1, and HB-EGF. The proteinase domain of ADAM-12 can cleave extracellular matrix components and growth factor precursors, influencing tissue remodeling and growth factor bioavailability. ADAM-12 also participates in mechanosensing and cytoskeletal remodeling through interactions with podosomes and extracellular matrix-associated proteins, as reviewed by Velmurugan et al. (2026). Given its involvement in both physiological repair and pathological remodeling, ADAM-12 has been explored as a prognostic marker in lung adenocarcinoma and other malignancies. The availability of domain-specific antibodies targeting the aminoterminal region allows researchers to probe ADAM-12 localization, expression, and proteolytic processing across multiple tissue contexts.

References

  1. Lin D et al (2026) Involvement of ADAM12 in TGF-β1-Induced Proliferation of Rheumatoid Arthritis Synovial Fibroblasts. Acta Med Okayama. PubMed · 10.18926/AMO/70450
  2. Wu S et al (2026) ADAM12 Stabilizes EIF3B to Promote Glycolysis and Tumor Progression in Hepatocellular Carcinoma. J Hepatocell Carcinoma. PubMed · 10.2147/JHC.S560478
  3. Tavares TSDC et al (2026) Parenchymal and stromal adaptations to hypoxia in adenoid cystic carcinoma and mucoepidermoid carcinoma: a comparative immunohistochemical analysis of HIF-1α, NOTCH-1, ADAM-12 and HB-EGF. Oral Surg Oral Med Oral Pathol Oral Radiol. PubMed · 10.1016/j.oooo.2026.04.003
  4. Velmurugan G et al (2026) The dynamics of podosomes, extracellular matrix-associated proteins regulate the cytoskeletal remodeling, mechanosensing, migration in Tau. Adv Protein Chem Struct Biol. PubMed · 10.1016/bs.apcsb.2025.10.021
  5. Alghamdi B (2026) Exploring hypoxia-related genes as prognostic indicators in lung adenocarcinoma. PLoS One. PubMed · 10.1371/journal.pone.0349820

Additional Specifications

Gene Symbol ADAM12
UniProt ID O43184
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Aminoterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 208-258.
Immunogen (Cytoplasmic domain ADAM-12 (long form))Immunogen is proprietary and confidential. Immunogen generated in amino acid region 730-909.
Immunogen (Amino end of catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 214-254.
Alternate Names Disintegrin and metalloproteinase domain-containing protein 12, ADAM 12, ADAM-12, Meltrin-alpha, Meltrin alpha, EC 3.4.24.-

Frequently Asked Questions

What molecular weight band should I expect for ADAM-12 on Western blot?

Full-length ADAM-12 runs at approximately 90-120 kDa on Western blot, though the exact mobility depends on glycosylation status and which isoform is expressed. ADAM-12L (the long, membrane-bound form) typically appears around 120 kDa, while ADAM-12S (the short, secreted isoform lacking the transmembrane domain) migrates closer to 90 kDa. If you are working with cell lysates that secrete ADAM-12, you may detect both forms. Post-translational modifications, particularly N-glycosylation within the disintegrin and cysteine-rich domains, can cause additional heterogeneity in migration.

What starting dilution should I use for ADAM-12 Western blot?

We recommend starting at 1:1000 for Western blot, which has been validated in-house with human lysates. Depending on ADAM-12 expression levels in your specific cell type or tissue, you may need to adjust between 1:500 and 1:2000. Muscle tissues and activated fibroblasts generally express ADAM-12 at detectable levels with overnight incubation at 4°C. If you are working with low-abundance samples or investigating ADAM-12 upregulation under hypoxic or inflammatory conditions, starting at 1:500 may improve signal without substantially increasing background.

Is this ADAM-12 antibody validated in mouse samples?

Human reactivity has been validated; mouse reactivity is predicted based on sequence homology but has not been formally validated by Triple Point Biologics. Human and mouse ADAM-12 share approximately 85 percent identity across the metalloproteinase and disintegrin domains, which are common epitope regions for polyclonal antibodies. We recommend running a positive control (human lysate or recombinant ADAM-12) in parallel with your mouse samples on the first blot. If you observe specific bands at the expected molecular weight in mouse, the cross-reactivity is likely sufficient for your application.

What are good positive and negative control cell lines for ADAM-12 expression?

Skeletal muscle myoblasts (such as human primary myoblasts or C2C12 mouse myoblasts during differentiation) are reliable positive controls, as ADAM-12 is upregulated during fusion. Many carcinoma lines, including MDA-MB-231 breast cancer cells, also express ADAM-12 at detectable levels, particularly under hypoxic culture conditions. For a negative control, consider using non-transformed epithelial lines with low basal metalloproteinase activity or ADAM-12 knockout cells if available. Comparing lysates from proliferating versus differentiating myoblasts can also serve as an internal dynamic-range control.

Can I use this antibody for immunofluorescence on fixed muscle sections?

Yes, Triple Point Biologics antibodies are validated for immunofluorescence and immunohistochemistry applications. For skeletal muscle cryosections, we suggest starting at a dilution between 1:100 and 1:200 after fixation in four percent paraformaldehyde or cold methanol. ADAM-12 localizes to the plasma membrane in myoblasts and at fusion sites, so you should observe peripheral staining in differentiating cultures. Antigen retrieval is typically not required for frozen sections, but if you are working with paraffin-embedded tissue, citrate buffer retrieval (pH 6.0) often improves signal.

Does this antibody distinguish between ADAM-12L and ADAM-12S isoforms?

This polyclonal antibody recognizes epitopes common to both the long membrane-anchored (ADAM-12L) and short secreted (ADAM-12S) isoforms, so it will not selectively detect one over the other by Western blot. The two isoforms differ in molecular weight (approximately 120 kDa versus 90 kDa), allowing you to infer which form is present based on band position. If your experimental question requires isoform-specific detection, consider fractionating cell lysates into membrane and secreted fractions, or use isoform-selective primers to confirm mRNA expression in parallel.

How should I prepare cell lysates to preserve ADAM-12 detection?

Use a lysis buffer containing protease inhibitors, particularly metalloproteinase inhibitors such as EDTA or 1,10-phenanthroline, to prevent autocatalytic cleavage or degradation by other matrix metalloproteinases in your lysate. RIPA buffer supplemented with protease inhibitor cocktail works well for total cell lysates. If you are specifically interested in the membrane-associated ADAM-12L isoform, include a non-ionic detergent such as one percent Triton X-100 to solubilize membrane proteins efficiently. Avoid repeated freeze-thaw cycles, which can lead to aggregation or proteolytic degradation of high-molecular-weight metalloproteinases.

What is the recommended storage condition and shelf life for this antibody?

Store the antibody at –20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The 100 µg pack size is supplied in a glycerol-containing buffer that remains stable for at least 12 months when stored properly. For long-term storage beyond one year, keep aliquots at –80°C. Once thawed, an aliquot can be held at 4°C for up to one month if sodium azide is present as a preservative. Always centrifuge briefly before use to pellet any aggregates that may have formed during storage.

Validation imagery coming soon

Western blot validation figures for RP-ADAM12 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • Disintegrin and metalloproteinase domain-containing protein 12
  • ADAM 12
  • ADAM-12
  • Meltrin-alpha
  • Meltrin alpha
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →